When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EMHTF - FDA OKs Boehringer Ingelheim's Ofev for rare lung disease
Emerald Health Therapeutics
The FDA approves privately held Boehringer Ingelheim's Ofev (nintedanib) to slow the rate of decline in pulmonary function in adult patients with interstitial lung disease associated with systemic sclerosis, a rare disorder of unknown cause characterized by diffuse scarring and vascular abnormalities in the internal organs, skin and joints, or scleroderma, a chronic connective tissue disorder characterized by the hardening and tightening of the skin and connective tissues.
More news on: Kadmon Holdings, Inc., Corbus Pharmaceuticals Holdings, Inc., Galapagos NV, Healthcare stocks news,